CLINICAL TRIAL PATIENT TECHNOLOGY INSIGHTS
-
HTA, Digital Twins, And Building Clinical Tech That Lasts
ISPOR CEO Rob Abbott on HTA-integrated trial design, digital twin evidence gaps, SaMD’s continuous update problem, and the one change he’d mandate for clinical tech.
-
Real-World Evidence And Wearables Are Reshaping Trial Tech
ISPOR’s Rob Abbott on why RWE moved to number two in the 2026-2027 HEOR Trends Report, and what wearables, data fragmentation, and HARPER+ mean for clinical platforms.
ECOA RESOURCES
-
How can you combat the instrument licensing and linguistic validation challenges associated with adopting electronic Clinical Outcome Assessments (eCOA), ensuring quick access to source files?
-
European regulatory shifts now require the systematic integration of patient data. Success depends on aligning clinical and market access strategies through rigorous evidence generation.
-
In this webinar, eCOA experts will explore how to implement a BYOD strategy, relevant BYOD regulatory considerations, and where the market is going from here.
ECONSENT RESOURCES
-
Learn the distinctions between a Waiver of Consent and a Waiver of Written Consent in clinical trials, and the importance of informed consent, particularly in the context of virtual trials.
-
See how a team of four managed data for 40 peer-reviewed studies and 200,000 participants.
-
Discover how digital consent is working to enhance diversity, empower participants with education, drive quality data, and streamline operations.
EPRO RESOURCES
-
FDA urges sponsors and CROs to include patient voices in oncology trials. Discover why it matters and how to start integrating this approach.
-
See how a team of four managed data for 40 peer-reviewed studies and 200,000 participants.
-
With the FDA stating last fall that the “patient’s voice” is key to understanding real-world-impacts, eCOAs and ePROs are becoming quintessential tools for cancer trials.